Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 146-154

  Liu, Xinyan ^a   Ukai, Takashi ^a,b   Yumoto, Hiromichi ^a,c   Davey, Michael ^d   Goswami, Sulip ^a   Gibson III, Frank C ^a   Genco, Caroline A ^a,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Unit of Translational Medicine   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Inflammation; Macrophages; Toll like receptor

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; FAT INTAKE; FEMALE; FOAM CELL; GENE EXPRESSION; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; FOAM CELLS; INFLAMMATION; MALE; MICE; MICE, KNOCKOUT; TOLL-LIKE RECEPTOR 2;

EID: 38049029104     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.03.025     Document Type: Article

References (37)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 9 (2002) 1135-1143
2. Hansson G. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 16 (2005) 1685-1695
3. Skalen K., Gustafsson M., Rydberg E.K., et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417 6890 (2002) 750-754
4. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14 5 (2003) 421-430
5. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 1 (2005) 1-14
6. O'Neill L.A. DisSARMing Toll-like receptor signaling. Nat Immunol 7 10 (2006) 1023-1025
7. Xu X.H., Shah P.K., Faure E., et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104 25 (2001) 3103-3108
8. Edfeldt K., Swedenborg J., Hansson G.K., et al. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105 10 (2002) 1158-1161
9. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 3 (2002) 185-192
10. Bjorkbacka H., Kunjathoor V.V., Moore K.J., et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10 4 (2004) 416-421
11. Michelsen K.S., Wong M.H., Shah P.K., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101 29 (2004) 10679-10684
12. Mullick A.E., Tobias P.S., and Curtiss L.K. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115 11 (2005) 3149-3156
13. Zhang S.H., Reddick R.L., Piedrahita J.A., et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 5081 (1992) 468-471
14. Plump A.S., Smith J.D., Hayek T., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 2 (1992) 343-353
15. Zhang S.H., Reddick R.L., Burkey B., et al. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 94 3 (1994) 937-945
16. Frostegard J., Ulfgren A.K., Nyberg P., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145 1 (1999) 33-43
17. Zhou X., Paulsson G., Stemme S., et al. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 101 8 (1998) 1717-1725
18. Robertson A.K., Zhou X., Strandvik B., et al. Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol 59 3 (2004) 285-293
19. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 7 (2006) 508-519
20. Reddick R.L., Zhang S.H., and Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14 1 (1994) 141-147
21. Tangirala R.K., Rubin E.M., and Palinkski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36 (1995) 2320-2328
22. Miyamoto T., Yumoto H., Takahashi Y., Davey M., Gibson F.C., and Genco C.A. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization. Infect Immun 74 (2006) 1376-1380
23. Qi M., Miyakawa H., and Kuramitsu H.K. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 35 6 (2003) 259-267
24. Zarember K.A., and Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 2 (2002) 554-561
25. Yumoto H., Chou H.H., Yakahashi Y., Davey M., Gibson F.C., and Genco C.A. Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion. Infect Immun 73 12 (2005) 8050-8059
26. Wang T., Lafuse W.P., and Zwilling B.S. Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 165 11 (2000) 6308-6313
27. Charo I.F., and Taubman M.B. Chemokines in the pathogenesis of vascular disease. Circ Res 95 9 (2004) 858-866
28. Martinovic I., Abegunewardene N., Seul M., et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J 69 12 (2005) 1484-1489
29. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88 12 (1991) 5252-5256
30. Nelken N.A., Coughlin S.R., Gordon D., et al. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88 4 (1991) 1121-1127
31. Gosling J., Slaymaker S., Gu L., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103 6 (1999) 773-778
32. Boring L., Gosling J., Cleary M., et al. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 6696 (1998) 894-897
33. Aiello R.J., Bourassa P.A., Lindsey S., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 19 6 (1999) 1518-1525
34. Hoebe K., Georgel P., Rutschmann S., et al. CD36 is a sensor of diacylglycerides. Nature 433 7025 (2005) 523-527
35. Kunjathoor V.V., Febbraio M., Podrez E.A., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem 277 51 (2002) 49982-49988
36. Suzuki H., Kurihara Y., Takeya M., et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386 6622 (1997) 292-296
37. Tamura Y., Osuga J., Adachi H., et al. Scavenger receptor expressed by endothelial cells I (SREC-I) mediates the uptake of acetylated low density lipoproteins by macrophages stimulated with lipopolysaccharide. J Biol Chem 279 30 (2004) 30938-30944